tiprankstipranks
Trending News
More News >
Foghorn Therapeutics sees cash runway into 2027
PremiumThe FlyFoghorn Therapeutics sees cash runway into 2027
23d ago
Is FHTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is FHTX a Buy, Before Earnings?
27d ago
Foghorn Therapeutics Appoints New Board Members
Premium
Company Announcements
Foghorn Therapeutics Appoints New Board Members
1M ago
Foghorn Therapeutics initiated with an Outperform at Citizens JMP
PremiumThe FlyFoghorn Therapeutics initiated with an Outperform at Citizens JMP
1M ago
Promising Advancements and Strategic Collaborations Position Foghorn Therapeutics as a Strong Buy
Premium
Ratings
Promising Advancements and Strategic Collaborations Position Foghorn Therapeutics as a Strong Buy
3M ago
Promising Potential of Foghorn Therapeutics’ FHD-909 Drives Buy Rating Amid Strategic Advances
Premium
Ratings
Promising Potential of Foghorn Therapeutics’ FHD-909 Drives Buy Rating Amid Strategic Advances
3M ago
Foghorn Therapeutics Advances Drug Development in Oncology
PremiumCompany AnnouncementsFoghorn Therapeutics Advances Drug Development in Oncology
4M ago
Foghorn Therapeutics initiated with a Buy at B. Riley
Premium
The Fly
Foghorn Therapeutics initiated with a Buy at B. Riley
4M ago
Foghorn Therapeutics files $300M mixed securities shelf
Premium
The Fly
Foghorn Therapeutics files $300M mixed securities shelf
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100